Nektar Therapeutics (NKTR) Return on Sales (2010 - 2026)

Nektar Therapeutics' Return on Sales history runs 17 years deep, the most recent figure standing at 0.04% for Q1 2026.

• In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.04%; the TTM figure through Mar 2026 stood at 0.03% (down 1.0% YoY), while the FY2025 annual figure was 0.03%, down 2.0% from the prior year.
• Return on Sales was 0.04% for Q1 2026 at Nektar Therapeutics, down from 0.02% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q4 2024 to a low of 0.07% in Q2 2022.
• Historically, Return on Sales has averaged 0.03% across 5 years, with a median of 0.02% in 2022.
• The sharpest annual moves came in 2022 and 2023: Return on Sales fell 3 bps in 2022, then grew 5 bps in 2023.
• A 5-year view of Return on Sales shows it stood at 0.03% in 2022, then soared by 37 bps to 0.02% in 2023, then surged by 114 bps to 0.0% in 2024, then tumbled by 741 bps to 0.02% in 2025, then sank by 149 bps to 0.04% in 2026.
• The last three Return on Sales figures came in at 0.04% (Q1 2026), 0.02% (Q4 2025), and 0.03% (Q3 2025), per Business Quant data.